PIERIS PHARMACEUTICALS INC (PIRS)
US7207952026 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 17.40M | 38.60M | 117.80M | 70.40M | 62.30M | |||
| Marketable Securities | 8.97M | 20.50M | N/A | 0.00 | 41.90M | |||
| Receivables | 6.04M | 5.80M | 3.30M | 1.70M | 6.80M | |||
| Other Current Assets | 6.28M | 8.40M | 6.50M | 3.60M | 4.10M | |||
| Total Current Assets | 38.68M | 73.40M | 127.60M | 75.70M | 115.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 20.70M | 23.00M | 26.00M | 22.90M | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 0.00 | 1.40M | 2.90M | 3.30M | 3.10M | |||
| Total Non-Current Assets | 0.00 | 22.10M | 26.00M | 29.30M | 26.10M | |||
| TOTAL ASSETS | 38.68M | 95.50M | 153.60M | 105.00M | 141.10M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 8.19M | 11.10M | 14.80M | 7.50M | 9.50M | |||
| Accounts Payable | 3.37M | 4.20M | 8.60M | 1.80M | 5.80M | |||
| Other Current Liabilities | 363.00K | 21.30M | 27.10M | 12.90M | 11.70M | |||
| Total Current Liabilities | 11.92M | 36.60M | 50.60M | 22.10M | 27.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 31.00M | 52.20M | 51.80M | 62.70M | |||
| Total Non-Current Liabilities | 0.00 | 31.00M | 52.20M | 51.90M | 62.70M | |||
| TOTAL LIABILITIES | 11.92M | 67.60M | 102.80M | 74.00M | 89.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -314.96M | -290.40M | -257.10M | -211.40M | -174.20M | |||
| Additional Paid In Capital | 341.60M | 318.50M | 307.00M | 242.70M | 227.50M | |||
| Common Shares | 98.00K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 28.00K | -300.00K | 800.00K | -300.00K | -2.00M | |||
| Shares Outstanding | 1.24M | 74.50M | 72.20M | 56.00M | 55.20M | |||
| Tangible Book Value per Share | 21.64 | 0.37 | 0.70 | 0.55 | 0.93 | |||
| Total Shareholders' Equity | 26.76M | 27.90M | 50.80M | 31.00M | 51.40M | |||
| TOTAL LIABILITIES AND EQUITY | 38.68M | 95.50M | 153.60M | 105.00M | 141.10M | |||
| Statistics | ||||||||
| Current Ratio | 3.24 | 2.01 | 2.52 | 3.43 | 4.26 | |||
| Return On Assets (ROA) | -63.45% | -34.85% | -29.78% | -35.46% | -20.06% | |||
| Return On Equity (ROE) | -91.72% | -119.28% | -90.04% | -120.10% | -55.06% | |||
All data in USD